The accurate representation of all aspects of a metabolic network in a structured format, such that it can be used for a wide variety of computational analyses, is a challenge faced by a growing number of researchers. Analysis of five major metabolic pathway databases reveals that each database has made widely different choices to address this challenge, including how to deal with knowledge that is uncertain or missing. In concise overviews, we show how concepts such as compartments, enzymatic complexes and the direction of reactions are represented in each database. Importantly, also concepts which a database does not represent are described. Which aspects of the metabolic network need to be available in a structured format and to what detail differs per application. For example, for in silico phenotype prediction, a detailed representation of gene^protein^reaction relations and the compartmentalization of the network is essential. Our analysis also shows that current databases are still limited in capturing all details of the biology of the metabolic network, further illustrated with a detailed analysis of three metabolic processes. Finally, we conclude that the conceptual differences between the databases, which make knowledge exchange and integration a challenge, have not been resolved, so far, by the exchange formats in which knowledge representation is standardized.
INTRODUCTION
Our understanding of metabolism is ever expanding, as evidenced by the increasing amount of bibliomic data. Pathway databases have been built to collect and capture this knowledge. Besides serving as knowledge repositories, the databases aim to represent the metabolic network in a digital format in such a way that it can be used for computational analyses. This has enabled numerous analyses ranging from the prediction of phenotypes [1] , studying evolution [2] , to the analysis and interpretation of high-throughput data [3] . The number of pathway databases describing the metabolic network for one or more organisms continues to grow [4, 5] .
From the perspective of a researcher used to the compact representation of biological knowledge on metabolism in a pathway, it may seem trivial to represent the metabolic network in an electronic form. However, the biology of the metabolic network is complex and the terminology used by biologists changes over time and varies among biologists [6] . Furthermore, a pathway database needs to accommodate a wide range of users with different requirements. Numerous choices need to be made by database developers and curators on how to represent and relate each component of the metabolic network ( Figure 1 ). Important considerations hereby are what needs to be described in a structured and standardized form to enable computational analyses and what can be described as background information in unstructured text fields.
We selected five, frequently used, pathway databases and compared their approach to represent the human metabolic network in a digital format. Gluconeogenesis. Selection of the information that needs to be stored to accurately represent the gluconeogenesis pathway [7] .
Furthermore, we discuss how the databases deal with knowledge that is uncertain or missing. To illustrate the challenges faced in making biological knowledge amenable to computational analyses, we give a detailed description of how each database represents three complex metabolic processes: fatty acid beta oxidation, oxidative phosphorylation and the pyruvate dehydrogenase reaction. Finally, we discuss the challenges posed by the differences in knowledge representation for analyses across pathway databases and exchange of knowledge between databases.
With this article, we intend to increase the awareness on the complexity of representing the current knowledge on metabolism. A detailed understanding of how knowledge is represented is crucial for users of pathway databases, as differences in representation can affect the outcome of computational analyses. As argued by Green and Karp [8] , the pathway definition alone may already influence analysis results. Moreover, the choices made in how to represent the metabolic network affect the ability of the database to capture every detail. By pointing out the current limitations, our research will also aid (future) database developers, knowledge curators and domain experts in their quest to further improve knowledge representation.
RESULTS
To illustrate the differences in representation of the metabolic network, we selected the following five databases: H. sapiens Recon 1 [9] from BiGG [10] (referred to as Recon 1 in the rest of the article), HumanCyc [11] from BioCyc [12] , EHMN [13] , KEGG [14] and Reactome [15] (Table 1) . Our analysis of how knowledge is represented in these databases was based on the descriptions given by the pathway database curators themselves in articles and online manuals (if available); when necessary we contacted the database curators for additional details. Moreover, for a more detailed insight we also examined the data files provided by each database, which contain the actual representation of the metabolic network (Supplementary Table S1 ). Note that we did not consider concepts that were only represented on the website of the database or knowledge that was only provided indirectly by references to other databases, e.g. metabolite databases. For each database, we analyzed how and to what detail knowledge is represented on the level of: (i) the entire network, (ii) its reactions and (iii) the enzymes and their encoding genes. On all three levels, the databases have made different choices ( Table 2) . We focused in our review on how knowledge is represented rather than how it is collected, although both issues are intimately linked to how accurately the metabolic network is captured.
Representation of the network
Types of networks An important difference on network level is whether a database only describes metabolic processes (EHMN, Recon 1) or also other types of biological processes such as signaling and genetic information processing (HumanCyc, KEGG, Reactome; Tables 2 and 3 ). Since in Reactome the different types of processes are intertwined, it is non-trivial to only retrieve the metabolic network, needed for instance to carry out flux balance analyses [16, 17] . Note that all five databases describe what is referred to as the global human metabolic network in which all possible reactions are combined, despite that they may not take place in every tissue or cell type. Defining tissue-specific models is left to algorithms like the one designed by Jerby et al. [1] or more specialized (manually) curated networks like HepatoNet1 [18] .
Compartmentalization
Different cellular compartments have distinct metabolic functions. KEGG does not provide any information on compartments. In HumanCyc, compartmentalization is work in progress, but their cell component ontology [19] does allow for a detailed representation. EHMN, Recon 1 and Reactome provide a fully compartmentalized network. Reactome has the most fine-grained compartmentalization of the latter three databases and thereby conveys the most detailed knowledge (Table 3) . Moreover, Reactome indicates the compartment not only for each reaction but also for each enzyme and even for some pathways. Recon 1 and EHMN account for the same set of eight compartments, but handle subcellular locations not included in this set differently. In Recon 1, the intermembrane space of the mitochondrion, for example, is merged with the cytosol [9] . EHMN uses the hierarchy of the Gene Ontology (GO) to determine which of their eight compartments is the ancestor of the subcellular location in question. In the example above, the ancestor is the mitochondrion. Such a more coarse-grained compartmentalization will result in a less accurate representation of, for example, oxidative phosphorylation (Supplementary Text S1).
Division into pathways
All five databases divided their network into pathways to provide insight into the functional organization of the metabolic network. Although this division into pathways is not arbitrary and is based on biological criteria in each of the databases, there is no generally accepted definition of a pathway. Consequently, each database defines the boundaries of its pathways differently (Table 3) . This results in a large difference in the number of pathways, the average number of reactions per pathway and the overlap between pathways ( Table 4) . As described by Green and Karp [8] for BioCyc and KEGG, the pathway definition might influence the outcome of pathway-based analyses. Reactome defines a pathway as a series of reactions, connected by their participants, leading to a biological outcome [21] . In HumanCyc, more strict guidelines are used, i.e. a pathway is a single biological process that should be evolutionary conserved and regulated as a unit [8] . This partly explains the low average size of a pathway in HumanCyc. Moreover, variants of the same metabolic process are considered as separate pathways, thereby increasing the overlap between pathways. In contrast, in EHMN the emphasis is on the functional relationships between reactions and overlapping metabolic processes are merged into a single pathway [22] . The pathways of KEGG are a mosaic of reactions that take place in any of the organisms included in KEGG and are substrate-centric [8] . The organism-specific version of a KEGG pathway consists of those reactions to which a gene of the If it is a transport reaction, the compartment is only indicated at the metabolite level.
e If it is a transport reaction, the compartment is indicated at the metabolite level, otherwise only for the entire reaction. GO, Gene Ontology; EMP, Enzymes and Metabolic Pathways database. Statistics based upon the same data we used previously [20] for a comparison of the content of the five databases. Only the metabolic pathways of HumanCyc, KEGG and Reactome are considered. For Reactome and HumanCyc the lowest level in the hierarchy was used when counting the number of pathways. If reactions only differ in direction and/or compartments they are counted as one.
a With respect to the total number of reactions assigned to at least one pathway.
organism of interest has been linked. This approach can result in artifacts. For example, 'lysine biosynthesis' is part of the human metabolic network in KEGG, although our metabolism lacks the ability to synthesize lysine. Recon 1 uses the same pathway definitions and categories as KEGG; however, only human-specific pathways are included and, e.g. lysine biosynthesis is not included in Recon 1. Ultimately, pathways cannot be studied in isolation as the entire network is connected.
Representation of metabolic reactions
A metabolic reaction can be defined as the synthesis or degradation of chemical compounds, which may or may not be a reversible process. The type of reaction, e.g. an 'oxidation-reduction' reaction, is indicated by an Enzyme Commission (EC) number in all databases, although in Reactome a link to GO is preferred. KEGG and HumanCyc also have their own reaction ontology ( Table 5 ). The ontology of HumanCyc enables selecting, for instance, only small molecule reactions. The exact representation of a metabolic reaction differs per database. For example, each database uses a different terminology in its data model to refer to the metabolites before the arrow, e.g. 'substrates' or 'input', and after the arrow, e.g.
'products' or 'output' (Figure 2 ). In addition, the level of detail in which a conversion is described varies within and between databases (see 'Case Study' section and Supplementary Text S2). Differences in detail between databases can reflect a disagreement on the number of steps required for the conversion. Intermediate steps may, however, also have been left out because of a lack of evidence or to simplify the description of a process. For these reasons, an apparent disagreement on the underlying biology between multiple descriptions of the metabolic network could also be caused by different decisions on how to represent the same knowledge. If intermediate steps have been left out for simplification only, a mechanism to retrieve these steps should be provided to allow users to determine themselves the level of detail that is required for the application at hand. Only HumanCyc enables its curators to indicate 'subreactions', but this option has not been used yet (release 15.5). The reasons for leaving out intermediate steps are not indicated in a structured way in any of the databases.
Linking of reactions
For various types of network analysis, first the network needs to be constructed from the individual reactions in a pathway database [23] . In HumanCyc, KEGG and Reactome reactions are explicitly linked to the preceding and/or following steps both within pathways as well as across pathways (Table 5) . For each reaction, KEGG also stores its main compounds, which connect consecutive reactions. In HumanCyc, the main compounds are deduced automatically per pathway for most reactions [24] and in Reactome main compounds are only captured in the graphical representation of the pathway. Note that in Reactome a metabolic reaction can be preceded by the activation of an enzyme catalyzing this reaction. This gives a more complete view of a biological process, compared to only describing its metabolic component. However, as stated above, retrieving solely the metabolic processes from Reactome is difficult. How to link reactions to each other is not explicitly indicated in EHMN and Recon 1. In this case, reactions are generally linked based on the substrates or products they have in common. This strategy makes network construction more difficult due to 'currency' metabolites (ATP, H þ , etc.) connecting unrelated reactions [25] . The number of possible connections can be restricted by only linking reactions via metabolites that are assigned to the same compartment.
Physiological direction
Knowing the physiological direction of reactions is crucial when, for example, building an in silico model to predict phenotypes. All databases indicate the direction in slightly different ways ( Figure 2 , Table 5 ). In general, reactions in EHMN, HumanCyc and KEGG are stored in the direction defined by NC-IUBMB, which is not necessarily the physiological direction in which the reaction takes place in human. For example, the last step of glycolysis, the formation of pyruvate, is given in the direction opposite to the one in which it takes place ( Figure 2A ). EHMN only indicates that the reaction is irreversible and thus does not provide the correct physiological direction. In KEGG, (ir)reversibility of a reaction is indicated independently of the specific organism, hereby ignoring that whether a reaction is reversible or not varies among species. Note that in Reactome reversibility is only indicated by providing a link to the reaction in the opposite direction if the reaction is reversible. Finally, only in HumanCyc the direction can be defined in the context of: (i) a specific enzyme that catalyzes the reaction, (ii) the pathway or (iii) only the reaction itself. Only for 4% of the reactions, mainly transport reactions, the direction is specified in the context of the enzyme. Furthermore, for 40% of the reactions the direction is not specified at all. These reactions are also not included in any pathway.
Metabolites
The identity of a metabolite is determined by its name and by identifiers from specialized metabolite databases such as ChEBI [26] . An identifier is meant to unambiguously designate a metabolite across multiple resources. Identifiers enable, for example, mapping of experimental data onto the network. All five databases try to link a metabolite to at least one specialized metabolite database. The number of metabolite databases referred to differs (Supplementary  Table S2 ). To minimize ambiguity, it is advisable that pathway databases provide a link to a single, common metabolite database for every metabolite. However, in practice this is not possible yet, as metabolite databases are far from complete.
Metabolite databases use different criteria for assigning IDs to metabolites. Consequently, the type of ID chosen affects the characterization of a metabolite in a pathway database and the level of distinction that can be made. For example, in ChEBI, both a base and its conjugate acid are assigned separate IDs, whereas in KEGG Compound no distinction between these two is made and they are combined in a single entry with one ID. KEGG, EHMN and Reactome prefer to state the neutral form of the metabolite. This choice may result in a different ChEBI ID compared to the one assigned to a metabolite by Recon 1 and HumanCyc, which specify the most common protonation state of a metabolite at a pre-defined and fixed pH level. Indicating the correct protonation state is important to be able to build a charge-balanced network. As the pH level varies between compartments, metabolites may have multiple protonation states. Ideally, databases should also be able to indicate these multiple states, which is currently not the case in any of the databases.
The pathway databases have made different choices with respect to how much information about metabolites is contained in the pathway database itself. EHMN, Recon 1 and Reactome contain the least information on metabolites and refer to specialized metabolite databases for additional information. Aside from referring to metabolite databases, KEGG and HumanCyc themselves also provide detailed information about metabolites (Table 6) . KEGG even has its own metabolite database (KEGG Compound), which is often referred to by many other pathway databases. HumanCyc and KEGG also provide their own hierarchical classification of the metabolites (Table 5 , Supplementary  Figure S1 ), although not as extensively as ChEBI. These ontologies are a powerful way to provide some level of abstraction, and at the same time explicitly define what is meant by the abstract term. HumanCyc uses compound classes, e.g. 'an alcohol', in reactions as a level of abstraction. Such generic metabolites are, in general, linked to specific metabolites and used to represent the broad substrate specificity of an enzyme (see 'Case Study' section). If for a generic metabolite no specific metabolites are provided at all, the substrate specificity of the enzyme is likely to be undetermined [27] . Especially when constructing a computational model, it is important to be able to instantiate such generic metabolites and derive specific reactions. For HumanCyc, a mechanism for instantiation of generic reactions has recently been added to their Pathway Tools software for the purpose of building flux balance analysis models [16] . Instantiation is done using the compound ontology by selecting those combinations of specific instances of the generic metabolites that lead to a massbalanced reaction. However, not for every generic reaction appropriate instances exist which fulfill this requirement. Moreover, part of the generic reactions cannot be instantiated because multiple products are possible for a given substrate (and vice versa). Recon 1 was specifically built to serve as an in silico model capable of predicting phenotypes. For this purpose, very generic reactions do not provide enough information and were therefore not included in Recon 1. The (broad) substrate specificity of an enzyme is, consequently, not explicitly captured in this database. In Reactome, some level of abstraction is given by grouping metabolites that undergo the same conversion into a set (Supplementary Figure S2) .
Representation of enzymes and their encoding genes
A metabolic reaction is nearly always catalyzed by an enzyme, which in turn is encoded by one or more genes (Figure 1 ). An enzyme may be a single protein or a complex consisting of multiple copies of the same protein (homomer) or of multiple different proteins (heteromer). The concepts of an enzyme and a gene are represented differently in each database or, in some cases, even not at all (Figure 3) . The same holds for the gene-proteinreaction relationship.
Enzymes
The concept of an enzyme, as defined above, is not explicitly represented in KEGG. Information on a protein, e.g. its sequence, is indicated at the gene level. Furthermore, aside from a few exceptions, complexes are not indicated in KEGG. EHMN merely represents an enzyme by the Uniprot ID(s) assigned to the protein(s) constituting the enzyme; also in EHMN complexes are not represented. In Recon 1, heteromeric complexes are represented using a Boolean expression. However, this is not done on protein level, as one would expect, but at gene level. Homomeric complexes are not represented at all. HumanCyc and Reactome do have a separate enzyme level and both types of complexes, i.e. heteromers and homomers, are represented.
Genes
A gene is defined by its Entrez Gene ID in EHMN, KEGG and Recon 1, while HumanCyc has its own definition which is closer to the definition of Ensembl. Reactome focuses more on proteins. Genes are not represented as a single entity in their MySQL database, but as a collection of identifiers from different genome databases (Figure 3) . The various identifiers provided by Reactome are only united through their link to the same protein entry. As for metabolite databases, also genome databases use different criteria for assigning an identifier. The answer to the seemingly simple question of how many genes are involved in the human metabolic network according to each pathway database depends on which type of identifier one counts or whether one follows the convention of the pathway database itself.
Gene^protein^reaction relationship
There is not necessarily a one-to-one relation between a reaction and the catalyst, e.g. multiple enzymes may catalyze the same reaction (isozymes) [28] . EHMN and KEGG do not specify whether the products of multiple genes linked to the same reaction are isozymes, which can separately catalyze the reaction, or that the products together form a complex. This could result in incorrect conclusions with respect to the feasibility of a reaction when studying the effect of a protein deficiency [10] . Furthermore, the EC number and KEGG Orthology number are used instead of a specific enzyme to connect a gene to the corresponding reaction in KEGG. Moreover, only the gene level is organism-specific and the relation between 'enzyme activity' (EC number) and reaction is not. To retrieve species-specific reactions, the gene coding for the enzyme that catalyzes a reaction needs to be known. In Recon 1, the relation between a protein and the encoding gene is only available via its website. Isozymes are represented using a Boolean expression and are defined on gene level in Recon 1. Reactome groups isozymes on enzyme level into a set, each member of which can catalyze the reaction it is linked to. In HumanCyc, isozymes are implied when multiple proteins are separately linked to the same reaction ( Figure 3) . None of the five databases indicates tissue specificity of isozymes and isoforms, aside from statements in unstructured comment fields, which cannot easily be used in computational analyses.
Representation of uncertain and missing knowledge
Our current knowledge on human metabolism is incomplete and based on different types of evidence such as biochemical, genetic or sequence data and studies on other organisms. It is, therefore, important that databases explicitly indicate the source of a piece of knowledge and the degree of confidence associated with it. The databases, except EHMN, commonly cite scientific articles as evidence source. HumanCyc and Recon 1 also indicate the type of evidence available (Table 7) . HumanCyc uses an evidence ontology [29] with 160 terms such as 'Inferred from experiment', which can be combined with a probability that the evidence is correct. However, evidence codes are available for <18% of the reactions and their catalyzing enzymes. Evidence codes are available for each pathway as a whole. In Recon 1, the type of evidence is indicated for each reaction. Five types of evidence are discerned which are assigned a confidence score (Table 7 ) [30] .
It is also important to explicitly indicate a complete lack of information, which is, however, rarely done. In Recon 1, for instance, 'cytosol' is used as the default value if the compartment is unknown, instead of explicitly indicating that there is a lack of knowledge as done in EHMN (Table 7) . Similarly, of the five databases, only HumanCyc explicitly distinguishes a spontaneous reaction from a reaction for which the enzyme is unknown. In KEGG, spontaneous reactions are only indicated in unstructured In Reactome, a 'BlackBoxEvent' can be used for this, which, however, does not necessarily mean that the intermediary steps are unknown.
CASE STUDY
We selected three complex metabolic processes to further illustrate the different challenges faced by the pathway databases in accurately representing the metabolic network in silico. Here, we discuss fatty acid beta oxidation [31] in more detail. Two more examples, oxidative phosphorylation [32] and the pyruvate dehydrogenase reaction [33] , are discussed in the Supplementary Text S1 and S2, respectively. These three case studies show the implications of different design decisions on the ability of the pathway databases to represent a biological process in full detail.
Fatty acid beta oxidation
We focused on the beta oxidation of saturated fatty acids with a straight chain of even length. One particular challenge in representing this pathway is the repetitive nature of this process. The chain of an activated fatty acid is shortened by two carbons via four subsequent reactions, yielding one unit of acetyl-CoA. Several chain-length-specific isozymes are available for each cycle. For the complete oxidation of a fatty acid, this cycle is repeated until only acetyl-CoA is left. The number of cycles needed depends on the chain length of the fatty acid. There is a wide range of fatty acids of which the majority, i.e. short-chain, medium-chain and long-chain fatty acids, are degraded in the mitochondrion. In mammals and many fungi, very-long-chain fatty acids are first shortened in the peroxisome after which they may be transported to the mitochondrion for further oxidation [34] . The exact enzymes involved differ in the two compartments, but the reactions are the same except for the co-substrates of the first step of a cycle.
Representation
Each database has its own strengths and limitations in representing fatty acid beta oxidation (Table 8) . KEGG and HumanCyc make no distinction between the peroxisomal and mitochondrial pathway, which emphasizes the similarities, but disregards the differences. For KEGG, it is difficult to separate the two pathways, since KEGG does not provide information on compartments. Moreover, as mentioned above, pathways in KEGG are not species-specific and the distinction between the peroxisomal and the mitochondrial pathway does not hold for the majority of organisms described in KEGG. In HumanCyc, the repetitive nature of this metabolic process is captured by describing a single cycle, using generic metabolites to describe the oxidation for the complete range of saturated fatty acids. Furthermore, a 'polymerization link' explicitly connects the fatty acid before and after the removal of the 2-carbon acetyl-CoA (Figure 4 ). Which combinations of instances of the generic metabolites together form the specific reactions is, however, not explicitly indicated. Moreover, in this particular example, several of the required metabolite instances for each of the four steps are lacking. The chain length specificity of the enzymes is also not captured in HumanCyc. Reactome chooses to represent the repeating cycles of the mitochondrial pathway as separate subpathways and to describe each step of every cycle. In this way, Reactome is able to represent the chain length specificity of each enzyme. Note though that all four steps in the peroxisomal pathway are described for one cycle only, the next eight cycles are lumped into a single step. No mechanism is provided that allows users to retrieve the intermediate steps of these eight cycles. Similarly, in Recon 1 the repetitive nature of this process is not captured as the conversion of, for example, palmitoyl-CoA into octanoyl-CoA is described in a single step instead of 16 steps. Also, the four steps of a single cycle are described for none of the fatty acids. This decision is indicated in the comment field, but the intermediate steps cannot be retrieved. Describing each step is, however, important to be able to simulate enzyme deficiencies that lead to the abnormal build up of intermediate products of a cycle of beta oxidation [35] [36] [37] [38] . In EHMN and KEGG, every step is described for fatty acids with a chain of length 16 or shorter, but not for those with a longer chain Check mark, concept is represented; Cross, concept is not represented; Bar, not for all cases the concept is represented.
a Not all possible fatty acids are specified as instances for each of the generic metabolites. For the mitochondrial pathway each step of all cycles is described. For the peroxisomal pathway eight of the nine cycles are summarized in a single reaction ('BlackBoxEvent').
length. A disadvantage of describing every step is that, in contrast to the generic approach of HumanCyc, it requires that each of the highly similar steps needs to be specified separately for the whole range of possible fatty acids. Moreover, not for all applications the intermediate steps are of interest. A mechanism that allows database users to switch between a high-level and a more detailed representation would be preferred.
CHALLENGES Within a database
It remains a challenge to capture every detail of the knowledge on the human metabolic network, both for relatively straightforward processes like gluconeogenesis ( Figure 1 ) and the more complex processes illustrated by the three case studies. On the other hand, the question which level of detail is required to be able to perform a wide range of possible computational analyses does not always have a clear-cut answer. For example, to represent a (de)polymerization processes it is not always an option nor always strictly necessary to specify each step. The degradation of glycogen, for instance, consists of thousands of steps [39] , but not each intermediate product might be of interest. Furthermore, it is also important for users to have some degree of abstraction, such as the ontologies provided by some databases, to see how everything fits in the bigger picture.
Unstructured text fields in the databases, which cannot be easily used in computational analyses, frequently contain more detailed information, such as the tissue specificity of an enzyme. As argued by Khatri et al. [40] , tissue-and cell-specific information is essential to improve the accuracy and relevance of pathway analyses. In the Biological Connection Markup Language format [41] that was recently proposed, this information can be stored, but this format has not yet been adopted by the major databases. Ultimately, there are even more factors to consider to accurately capture the complete (human) physiology in a digital format. This includes the inherent dynamics of metabolic processes and the multiple levels at which these processes are being controlled. The complexity of metabolism is further increased by its multi-scale nature ranging from cellular compartments and cells to organs. These issues are not (yet) addressed by the pathway databases selected in this review. However, several large-scale projects have taken up this challenge. For example, the goal of the Virtual Liver project (http://www.virtualliver.de) [42] is to construct a multi-scale representation of liver physiology.
The ability to indicate that a piece of knowledge is missing is another desirable characteristic of a pathway database. This is, however, not yet done in each database. A further extension of the pathway databases is to not only provide affirmative evidence as done by HumanCyc and Recon 1 but also indicate 'negative evidence' such as a statement that a reaction cannot take place in human. This would enable users to distinguish such cases from knowledge gaps. This information is highly valuable, especially given that the (human) metabolic network is not yet complete. Note that although we focused on the human network, most observations also hold for the other organisms the five databases describe (when applicable).
Across databases
Efforts to reconcile different descriptions of the metabolic network for a specific species are hampered by the representation differences discussed in this article [43] [44] [45] [46] . Similar problems arise in analyses that require the metabolic network of multiple organisms from different databases, e.g. to study evolution [2] . For these purposes, it is essential to be aware what differences could be caused by a difference in representation rather than a true difference in opinion on the underlying biology. One example is the number of steps a process is described in (see 'Case Study' section and Supplementary Text S2). Furthermore, it is important to realize that even the smallest difference in terminology and the definition of a concept needs to be accounted for.
To simplify the exchange of knowledge between databases, several standards have been proposed such as SBML and BioPAX, each with their own advantages [47] . However, these do not resolve all representational differences that we discussed. HumanCyc and Reactome provide their network in the BioPAX (Level 3) format [48] . They, however, followed their own representation when converting their data into this format. For example, in Reactome a reversible reaction is stored separately in both directions in their own data model and also in their BioPAX file. In HumanCyc's data model, a reversible reaction is stored only once and its direction is indicated as 'reversible'. The same is done in their BioPAX file. Semantic standards like BioPAX can also not enforce the level of detail in which a process needs to be described by a curator or how a pathway is defined. Curators will, therefore, need to adhere to strict guidelines to make these exchange formats more easily comparable. Alternatively, rules could be formulated to translate one representation into the other. Based on Figure 3 , for example, one could develop more precise rules to translate the different ways of representing the relations between gene products. The results of our comparison and the accompanying overviews provide useful insights in the road ahead to further simplify integration of the knowledge contained in pathway databases. Integration will also enable the construction of a more accurate in silico representation of metabolic networks. Endeavors in this direction have already been undertaken for multiple organisms [43, 45] , including human (I. Thiele et al., submitted for publication).
DISCUSSION
The five pathway databases each have made different decisions on how and in what detail to represent the metabolic network. Of these five databases, EHMN provides the least detailed information and HumanCyc the most (Table 2) . At the same time, not every aspect of the data model of HumanCyc is used yet. Filling in every detail will likely require a lot of time and effort from the curators. Moreover, the lack of knowledge on human metabolism may currently preclude the usability of every feature of HumanCyc's data model. It also depends on the application at hand which aspects of the metabolic network are important and to what detail they need to be represented in a structured format. The overviews given in this article provide insight into the differences between the databases and can help to make a well-informed decision on which database to use. The different choices the database developers have made each have their own advantages and disadvantages. For example, to perform in silico simulations and predicting metabolic phenotypes, Recon 1 may be preferred. This network is fully compartmentalized and fully mass and charge balanced. Also, the relation between gene products is provided, which is important for simulating the effect of, for example, gene defects. On the other hand, for pathway enrichment analyses [3] each of the five databases may suffice and the determining factor is the pathway definition used. Other factors than the representation of the network will also play a role in selecting the database that best fits the application, such as the coverage of the metabolic network [20] , e.g. EHMN contains a more extensive description of lipid metabolism than other databases. Finally, retrieving and capturing every detail of the (human) metabolic network in a digital format is a huge challenge and will require a joint effort of a broad scientific community.
SUPPLEMENTARY DATA
Supplementary data are available online at http:// bib.oxfordjournals.org/.
KEY POINTS
It remains a challenge to represent the biology of the metabolic network in full detail such that it: (i) accurately reflects the current knowledge and (ii) can be used for computational analyses. Metabolic pathway databases differ in what knowledge they represent, how it is represented and into what detail. It depends on the application at hand which aspects of the metabolic network are important and to what detail they need to be represented in a structured format. Differences between the representations of the metabolic network are not easily solved by semantic standards.
